- Home
- APLD vs SLNO Comparison
APLD vs SLNO Comparison
Compare APLD & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLD
- SLNO
- Stock Information
- Founded
- APLD 2001
- SLNO 1999
- Country
- APLD United States
- SLNO United States
- Employees
- APLD N/A
- SLNO N/A
- Industry
- APLD Investment Bankers/Brokers/Service
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- APLD Finance
- SLNO Health Care
- Exchange
- APLD Nasdaq
- SLNO Nasdaq
- Market Cap
- APLD 9.3B
- SLNO 3.7B
- IPO Year
- APLD N/A
- SLNO 2014
- Fundamental
- Price
- APLD $30.95
- SLNO $47.70
- Analyst Decision
- APLD Strong Buy
- SLNO Strong Buy
- Analyst Count
- APLD 11
- SLNO 9
- Target Price
- APLD $29.36
- SLNO $114.89
- AVG Volume (30 Days)
- APLD 32.1M
- SLNO 2.2M
- Earning Date
- APLD 10-09-2025
- SLNO 11-04-2025
- Dividend Yield
- APLD N/A
- SLNO N/A
- EPS Growth
- APLD N/A
- SLNO N/A
- EPS
- APLD N/A
- SLNO N/A
- Revenue
- APLD $173,560,000.00
- SLNO $98,675,000.00
- Revenue This Year
- APLD $113.90
- SLNO N/A
- Revenue Next Year
- APLD $71.28
- SLNO $181.30
- P/E Ratio
- APLD N/A
- SLNO N/A
- Revenue Growth
- APLD 28.43
- SLNO N/A
- 52 Week Low
- APLD $3.31
- SLNO $41.50
- 52 Week High
- APLD $40.20
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- APLD 49.27
- SLNO 31.94
- Support Level
- APLD $29.95
- SLNO $66.12
- Resistance Level
- APLD $33.90
- SLNO $69.99
- Average True Range (ATR)
- APLD 3.10
- SLNO 3.71
- MACD
- APLD -0.88
- SLNO -2.47
- Stochastic Oscillator
- APLD 30.29
- SLNO 18.57
About APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments: Data Center Hosting Business and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business, which operates data centers to provide energized space to crypto mining customers.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.